U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06907732) titled 'Fetoscopic Robotic Opens Spina Bifida Treatment' on Feb. 27.
Brief Summary: Fetal spina bifida is a common birth defect that results in hydrocephalus, motor-, bowel-, bladder- and sexual dysfunction in the child. The condition is progressive in utero. Fetal surgery between 22-26 weeks gestation has been shown to stop the gradual fetal deterioration observed in this disease and improve infant outcomes. Children with spina bifida who have undergone fetal surgery have a lower need for hydrocephalus treatment (80%->40%) and twice the chance to walk independently by the age of 3 years (20%->40%). These benefits are also sustained in the ...